by Dr. Paula Greaves – Chief, Women’s Health Service Line, Wellstar Health System
When we talk about improving outcomes, strengthening families, or building healthier communities, we are ultimately talking about the wellbeing of women. But that’s not always reflected in care models and research.
Women make up over 50% of the population, but women’s health receives just 2% of medical research funding and 4% of healthcare venture investment.
It’s time to change that. We need to invest in the MVPs of our society, the people who can change society for the better every day.
That’s why, at Wellstar Health System, our Women’s Health Service Line operates with a guiding principle: Every woman. Every time.
Too often, care is fragmented. Reproductive health may be the most visible aspect of women’s care, but it is only one chapter in a much longer journey. Women spend roughly 40% of their lives in midlife and beyond, and this phase—marked by perimenopause, menopause, and increasing chronic disease risk—is critically underserved.
Women spend roughly 40% of their lives in midlife and beyond, and this phase—marked by perimenopause, menopause, and increasing chronic disease risk—is critically underserved.
Dr. Paula Greaves – Chief, Women’s Health Service Line, Wellstar Health System
We must shift from reactive to proactive care, from generalized assumptions to personalized solutions.
At this year’s Aspen Ideas Health, I had the opportunity to share what it looks like to build that shift inside a health system. It starts with reimagining care pathways, yes—but also with rethinking how and where innovation happens. That’s where Catalyst by Wellstar comes in.
Two of our most meaningful innovation partnerships—Gabbi and Elektra Health—are helping us move the needle on this mission in real time. They are both Catalyst direct investments.
Gabbi, founded by Kaitlin Christine, is a precision health platform built to end late-stage breast cancer through earlier detection. Gabbi leverages machine learning and claims data to generate personalized risk assessments and care plans for women. For our patients at Wellstar, this means no more one-size-fits-all screening recommendations. Instead, a woman knows her risk and has a tailored plan—whether that’s earlier screening, additional imaging, or genetic counseling. One in eight women will develop breast cancer, and the disease is increasingly affecting younger women. Gabbi helps us identify risk earlier—and act faster.
Elektra Health, led by Jannine Versi, focuses on a different but equally urgent frontier: menopause care. Menopause affects every woman, yet education and support around it are alarmingly scarce. Elektra delivers evidence-based, compassionate care via digital platforms that empower women to understand their bodies, manage symptoms, and advocate for better health. At Wellstar, integrating Elektra helps us fill a long-ignored gap in care for women in midlife—at a time when they are often navigating both career and caregiving responsibilities alongside health changes.
Both Gabbi and Elektra reflect what we seek in innovation: not just new technology, but empathy. They are driven by lived experience, backed by science, and co-developed with our health system. And they help us deliver on our promise—every woman, every time.
Investing in women’s health isn’t just good medicine. It’s a strategy for equity, for economic vitality, and for generational change. I’m proud to be part of a system—and a moment—that is finally treating it that way.
